ACCESS Newswire
11 Aug 2022, 00:19 GMT+10
MILAN, ITALY / ACCESSWIRE / August 10, 2022 / Nephris, a biotech company developing first-in-class therapies for chronic kidney diseases, extends its congratulations to the researchers from the Romeo and Enrica Invernizzi Pediatric Clinical Research Center of the University of Milan who participated, along with Harvard Medical School, in a study published today in Science Translational Medicine. The study reports the results of research on NBL1 as a novel pathogenic factor in diabetic kidney disease, a discovery made by the scientific founders of Nephris, Dr. Paolo Fiorina and Dr. Francesca D'Addio, who were part of the group from the Invernizzi research center.
The collaborative effort also included researchers from Boston Children's Hospital and the Joslin Diabetes Center in Boston.
In the study, the researchers detailed the discovery that high circulating levels of NBL1 represent an independent predictor for the loss of renal function both in patients with type 1 diabetes and in patients with type 2 diabetes. The researchers explained that they used methods such as single cell RNAseq and immunostaining to examine the expression of NBL1 in renal cells and in various other tissues and to highlight for the first time the important role of this protein as a pathogenic factor in diabetic kidney disease.
Dr. Fiorina, Full Professor of Endocrinology and Director of the International Research Center for T1D at the Romeo and Enrica Invernizzi Pediatric Clinical Research Center, said the discovery 'would almost certainly improve our understanding of the mechanisms behind the development of diabetic nephropathy,' one of the most common complications of diabetes.
'For the first time we have identified a toxic factor directed against renal podocytes,' Dr. Fiorina added, 'demonstrating that there are specific factors beyond hyperglycemia that may represent a potential target for future therapies.'
'Congratulations to all of the teams who contributed to this valuable discovery,' said Gabriella Camboni, Chief Executive Officer of Nephris. 'A greater understanding of how diabetic nephropathy can develop increases the chances that clinicians will have better options to treat patients in the future.'
###
About Nephris
Nephris is a biotech company developing first-in-class therapies for chronic kidney diseases. Based in Milan, Italy, the company was founded by Paolo Fiorina, full professor of Endocrinology at the University of Milan and world-renowned authority in the domain, and Dr. Francesca D'Addio. The company was established through a €3 million seed financing from Sofinnova Telethon Fund, Sofinnova Partners' early-stage strategy focusing on rare genetic diseases. For more information, please visit: www.nephris.com
Contact
Gabriella Camboni
CEO, Nephris
[email protected]
SOURCE: Sofinnova Partners
Get a daily dose of Moscow Inquirer news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Moscow Inquirer.
More InformationDUBLIN, Ireland: Dublin has unveiled a new 5.5 million euro cycle track along the south quays, enhancing safety and accessibility for...
ABOARD THE CHARLES DE GAULLE, Philippines: France's nuclear-powered aircraft carrier and its warships arrived in the Philippines over...
DUBLIN, Ireland: Dublin has been ranked as the second most expensive city for apartment construction among ten major European locations,...
DUBLIN, Ireland: Ireland is positioning itself to host a high-profile gathering of European leaders next year, with Tanaiste Simon...
BRUSSELS/LONDON: The European Commission is preparing to ease sustainability reporting requirements for businesses as part of a broader...
DUBLIN, Ireland: Ireland's rental market continued to tighten in 2024, with average rents rising by 5.7 percent over the year, according...
MEXICO CITY, Mexico: Three American women were found dead over the weekend at a beach resort in Belize, police said. Officials are...
BANGKOK, Thailand: Chinese authorities said they started live-fire military exercises in the Gulf of Tonkin this week, just days after...
ABOARD THE CHARLES DE GAULLE, Philippines: France's nuclear-powered aircraft carrier and its warships arrived in the Philippines over...
FRESNO, California: Fresno State suspended two of its top men's basketball players last weekend and removed a third player from the...
WARSAW, Poland: Deputy Prime Minister Krzysztof Gawkowski confirmed over the weekend that Poland has been covering the cost of Ukraine's...
Israel sustained the West's support for its slaughter in Gaza for 15 months only through an intensive campaign of lies. It invented...